CWG
C WorldWide Group Portfolio holdings
AUM
$7.38B
This Quarter Return
-9.55%
1 Year Return
+18.35%
3 Year Return
+71.53%
5 Year Return
+105.42%
10 Year Return
+360.65%
AUM
$6.91B
AUM Growth
+$6.91B
(-11%)
Cap. Flow
-$3.91M
Cap. Flow
% of AUM
-0.06%
Top 10 Holdings %
Top 10 Hldgs %
70.94%
Holding
141
New
10
Increased
20
Reduced
68
Closed
19
Top Buys
| 1 |
American Tower
AMT
|
$337M |
| 2 |
Procter & Gamble
PG
|
$48.4M |
| 3 |
CVS Health
CVS
|
$36.9M |
| 4 |
US Bancorp
USB
|
$36.2M |
| 5 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$11M |
Top Sells
| 1 |
Citigroup
C
|
$355M |
| 2 |
Colgate-Palmolive
CL
|
$27M |
| 3 |
Visa
V
|
$18.3M |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
$9.59M |
| 5 |
Bristol-Myers Squibb
BMY
|
$7.46M |
Sector Composition
| 1 | Financials | 22.69% |
| 2 | Consumer Discretionary | 16.64% |
| 3 | Healthcare | 14.3% |
| 4 | Communication Services | 12.68% |
| 5 | Consumer Staples | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Weyerhaeuser
WY
$17.9B
| $25.5M | 0.37% |
1,164,423
| – | – |
|
27
Merck
MRK
$210B
| $25.2M | 0.36% |
329,955
| – | – |
|
28
Amgen
AMGN
$153B
| $21.6M | 0.31% |
110,716
| – | – |
|
29
Biogen
BIIB
$20.8B
| $13.3M | 0.19% |
44,165
-14,905
| -25% | -$4.49M |
|
30
Gilead Sciences
GILD
$140B
| $13M | 0.19% |
207,691
-5,413
| -3% | -$339K |
|
31
Boston Scientific
BSX
$159B
| $13M | 0.19% |
367,194
| – | – |
|
32
Vertex Pharmaceuticals
VRTX
$102B
| $12.2M | 0.18% |
73,337
-2,006
| -3% | -$332K |
|
33
Becton Dickinson
BDX
$54.3B
| $11.9M | 0.17% |
52,955
| – | – |
|
34
AbbVie
ABBV
$374B
| $11.6M | 0.17% |
125,780
| – | – |
|
35
HCA Healthcare
HCA
$95.4B
| $11.5M | 0.17% |
92,727
| – | – |
|
|
BHVN
36
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $11M | 0.16% |
+298,750
| New | +$11M |
|
37
Centene
CNC
$14.8B
| $10.8M | 0.16% |
93,653
| – | – |
|
38
Eli Lilly
LLY
$661B
| $10.6M | 0.15% |
91,848
| – | – |
|
39
Cigna
CI
$80.2B
| $10.2M | 0.15% |
53,825
+17,102
| +47% | +$3.25M |
|
|
AGN
40
DELISTED
Allergan plc
AGN
| $10.1M | 0.15% |
75,890
| – | – |
|
|
AMRN
41
Amarin Corp
AMRN
$311M
| $8.61M | 0.12% |
632,866
-47,134
| -7% | -$642K |
|
42
Hologic
HOLX
$14.7B
| $8.19M | 0.12% |
199,328
+66,697
| +50% | +$2.74M |
|
|
CELG
43
DELISTED
Celgene Corp
CELG
| $8.11M | 0.12% |
126,550
-247
| -0.2% | -$15.8K |
|
|
SHPG
44
DELISTED
Shire pic
SHPG
| $7.71M | 0.11% |
44,321
-34,357
| -44% | -$5.98M |
|
45
Viatris
VTRS
$12.3B
| $7.06M | 0.1% |
257,473
| – | – |
|
46
Edwards Lifesciences
EW
$47.7B
| $7.04M | 0.1% |
45,943
-46,450
| -50% | -$7.11M |
|
47
BioMarin Pharmaceuticals
BMRN
$11.3B
| $5.86M | 0.08% |
68,851
-6,580
| -9% | -$560K |
|
|
ALXN
48
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $5.02M | 0.07% |
51,600
-14,247
| -22% | -$1.39M |
|
49
TSMC
TSM
$1.2T
| $4.94M | 0.07% |
133,749
-24,220
| -15% | -$894K |
|
50
NovoCure
NVCR
$1.35B
| $4.72M | 0.07% |
141,094
-23,859
| -14% | -$799K |
|